These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Benzoquinone activation of Cryptococcus neoformans capsular polysaccharide for construction of an immunoaffinity column. Kozel TR; Hermerath CA J Immunol Methods; 1988 Feb; 107(1):53-8. PubMed ID: 3125258 [TBL] [Abstract][Full Text] [Related]
10. Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide. Dromer F; Salamero J; Contrepois A; Carbon C; Yeni P Infect Immun; 1987 Mar; 55(3):742-8. PubMed ID: 3546139 [TBL] [Abstract][Full Text] [Related]
11. An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan. van de Moer A; Salhi SL; Cherniak R; Pau B; Garrigues ML; Bastide JM Res Immunol; 1990 Jan; 141(1):33-42. PubMed ID: 2189167 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies. Mukherjee J; Kozel TR; Casadevall A J Immunol; 1998 Oct; 161(7):3557-68. PubMed ID: 9759877 [TBL] [Abstract][Full Text] [Related]
13. Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection. Abadi J; Pirofski La J Infect Dis; 1999 Sep; 180(3):915-9. PubMed ID: 10438394 [TBL] [Abstract][Full Text] [Related]
14. An enzyme-linked immunosorbent assay (ELISA) for human IgG antibody to the type Ia polysaccharide of group B streptococcus. Papierniak CK; Klegerman ME; Boyer KM; Kretschmer RR; Gotoff SP J Lab Clin Med; 1982 Sep; 100(3):385-98. PubMed ID: 7050270 [TBL] [Abstract][Full Text] [Related]
15. Purification of a Pasteurella haemolytica serotype 1-specific polysaccharide epitope by use of monoclonal antibody immunoaffinity. Austin FW; Corstvet RE Am J Vet Res; 1993 May; 54(5):695-700. PubMed ID: 7686355 [TBL] [Abstract][Full Text] [Related]
16. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. Kozel TR; Gotschlich EC J Immunol; 1982 Oct; 129(4):1675-80. PubMed ID: 7050244 [TBL] [Abstract][Full Text] [Related]
17. [The evaluation of the specific type of capsular polysaccharide of Cryptococcus neoformans as an immunogen and positive-control antigen]. Toraño Peraza GT; Rodríguez Acebo W; Martínez Machín G Rev Cubana Med Trop; 1998; 50(3):207-8. PubMed ID: 10349445 [TBL] [Abstract][Full Text] [Related]
18. Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D. Ikeda R; Nishikawa A; Shinoda T; Fukazawa Y Microbiol Immunol; 1985; 29(10):981-91. PubMed ID: 3908888 [TBL] [Abstract][Full Text] [Related]
19. Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays. Skovsted IC; Kerrn MB; Sonne-Hansen J; Sauer LE; Nielsen AK; Konradsen HB; Petersen BO; Nyberg NT; Duus JØ Vaccine; 2007 Aug; 25(35):6490-500. PubMed ID: 17655983 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan. Maitta RW; Datta K; Pirofski LA Vaccine; 2004 Sep; 22(29-30):4062-8. PubMed ID: 15364457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]